Looking back on Lausanne X

Last week, worldwide experts gathered at the milestone Lausanne X Workshop in Lausanne, Switzerland. In ten years, CEOi and the Lausanne Dialogues have driven important progress: becoming the premier global forum for convening across sectors, countries, and specialties, and successfully raising the alarm about the need for a global ecosystem and action plan.

At Lausanne X, stakeholders agreed on the importance of one overarching theme: Driving integrated systems for the discovery and delivery of innovative medicines and prevention interventions to persons living with or at risk of Alzheimer’s around the world through broadly accessible detection and diagnostic mechanisms.

Several high-level areas for action and collaboration can advance this goal:

1. Seize policy opportunities to accelerate Alzheimer’s innovation in medicines, risk mitigation, and health system delivery.
2. Challenge the status quo to democratize access to affordable Alzheimer’s detection, diagnosis, and treatment for all persons with or at risk of Alzheimer’s, particularly in resource-constrained settings.
3. Integrate blood-based biomarkers, digital cognitive assessments, and other new tools for detection and diagnosis into routine clinical care.
4. Create and align large-scale risk mitigation strategies, brain health assessments, and interventions in resource-constrained settings.
5. Define and accelerate the delivery of improved high-performing Alzheimer’s interventions, including active immunotherapies and vaccines.
6. Harness innovative models for financing, regulatory reviews, real-world evidence, brain health assessments, clinical trials, and other key areas for the delivery and adoption of evidence-based interventions.
7. Build the political willpower to link and scale global efforts, including in low-resource settings, to fund and deliver innovation at pace.